Dyne Therapeutics, Inc. has announced significant developments in its pursuit of accelerated approval for dyne-101, its investigational therapeutic for the treatment of myotonic dystrophy type 1 (DM1) ...
Erik Steiger discusses the operational pain of legacy PDF generation in regulated banking and manufacturing. He explains how ...
Abstract: In this article, we investigate the optimal control problem for an unknown linear time-invariant system. To solve this problem, a novel composite policy iteration algorithm based on adaptive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results